Swiss pharmaceutical giant Roche will focus future investments on markets that reward innovation, chief executive Thomas Schinecker said on Thursday, warning that Europe risks falling behind the United States and Asia.

The comments came after Roche said this week it was pausing investment decisions on Germany.